ITMI922826A1 - Composizione farmaceutica a rilascio controllato in sospensione liquida - Google Patents

Composizione farmaceutica a rilascio controllato in sospensione liquida

Info

Publication number
ITMI922826A1
ITMI922826A1 IT002826A ITMI922826A ITMI922826A1 IT MI922826 A1 ITMI922826 A1 IT MI922826A1 IT 002826 A IT002826 A IT 002826A IT MI922826 A ITMI922826 A IT MI922826A IT MI922826 A1 ITMI922826 A1 IT MI922826A1
Authority
IT
Italy
Prior art keywords
naproxen
administration
pharmaceutical composition
controlled release
liquid suspension
Prior art date
Application number
IT002826A
Other languages
English (en)
Inventor
Ettore Bilato
Giuseppe Bottoni
Giancarlo Santus
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of ITMI922826A0 publication Critical patent/ITMI922826A0/it
Priority to ITMI922826A priority Critical patent/IT1256651B/it
Priority to SG1996004299A priority patent/SG54207A1/en
Priority to EP93119587A priority patent/EP0601508B1/en
Priority to DE69324214T priority patent/DE69324214T2/de
Priority to ES93119587T priority patent/ES2132163T3/es
Priority to AT93119587T priority patent/ATE178209T1/de
Priority to JP5310680A priority patent/JPH06279274A/ja
Priority to US08/165,307 priority patent/US5527545A/en
Publication of ITMI922826A1 publication Critical patent/ITMI922826A1/it
Priority to US08/482,092 priority patent/US5670171A/en
Application granted granted Critical
Publication of IT1256651B publication Critical patent/IT1256651B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITMI922826A 1989-09-18 1992-12-11 Composizione farmaceutica a rilascio controllato in sospensione liquida IT1256651B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITMI922826A IT1256651B (it) 1992-12-11 1992-12-11 Composizione farmaceutica a rilascio controllato in sospensione liquida
ES93119587T ES2132163T3 (es) 1992-12-11 1993-12-06 Composicion farmaceutica de liberacion controlada en forma de suspension liquida.
EP93119587A EP0601508B1 (en) 1992-12-11 1993-12-06 Liquid-suspension controlled-release pharmaceutical composition
DE69324214T DE69324214T2 (de) 1992-12-11 1993-12-06 Pharmazeutische flüssige Suspensionszusammensetzung mit kontrollierter Freigabe
SG1996004299A SG54207A1 (en) 1992-12-11 1993-12-06 Liquid-suspension controlled-release pharmaceutical composition
AT93119587T ATE178209T1 (de) 1992-12-11 1993-12-06 Pharmazeutische flüssige suspensionszusammensetzung mit kontrollierter freigabe
JP5310680A JPH06279274A (ja) 1992-12-11 1993-12-10 懸濁液徐放性製薬組成物
US08/165,307 US5527545A (en) 1989-09-18 1993-12-10 Liquid-suspension controlled-release pharmaceutical composition
US08/482,092 US5670171A (en) 1989-09-18 1995-06-07 Liquid-suspension controlled-release pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI922826A IT1256651B (it) 1992-12-11 1992-12-11 Composizione farmaceutica a rilascio controllato in sospensione liquida

Publications (3)

Publication Number Publication Date
ITMI922826A0 ITMI922826A0 (it) 1992-12-11
ITMI922826A1 true ITMI922826A1 (it) 1994-06-11
IT1256651B IT1256651B (it) 1995-12-12

Family

ID=11364448

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI922826A IT1256651B (it) 1989-09-18 1992-12-11 Composizione farmaceutica a rilascio controllato in sospensione liquida

Country Status (7)

Country Link
EP (1) EP0601508B1 (it)
JP (1) JPH06279274A (it)
AT (1) ATE178209T1 (it)
DE (1) DE69324214T2 (it)
ES (1) ES2132163T3 (it)
IT (1) IT1256651B (it)
SG (1) SG54207A1 (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1270216B (it) * 1994-06-14 1997-04-29 Recordati Chem Pharm Metodo di stabilizzazione di composti biologicamente attivi mediante microgranuli ricoperti sospendibili in fluidi alimentari
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
DE19648576C2 (de) 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt
US6004582A (en) * 1997-05-30 1999-12-21 Laboratorios Phoenix U.S.A, Inc. Multi-layered osmotic device
SE9903879D0 (sv) * 1999-10-28 1999-10-28 Ethical Pharmaceuticals Sweden Multipor food protection
FR2822834B1 (fr) 2001-04-02 2005-02-25 Flamel Tech Sa Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
FR2837100B1 (fr) * 2002-03-18 2004-07-23 Flamel Tech Sa Comprimes a bases de microcapsules a liberation modifiee
ATE407674T1 (de) 2002-04-09 2008-09-15 Flamel Tech Sa Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin
EP1492511B3 (fr) 2002-04-09 2012-05-02 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
FR2843881B1 (fr) * 2002-09-02 2006-06-02 Flamel Tech Sa Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
FR2843117B1 (fr) 2002-07-30 2004-10-15 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
FR2860516B1 (fr) 2003-10-03 2006-01-13 Flamel Tech Sa Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
FR2862536B1 (fr) 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
US20060008527A1 (en) * 2004-07-09 2006-01-12 Yury Lagoviyer Controlled phase composition technology as an improved process for protection of drugs
US9962336B2 (en) 2014-05-01 2018-05-08 Sun Pharmaceutical Industries Limited Extended release suspension compositions
RU2016147009A (ru) 2014-05-01 2018-06-04 Сан Фармасьютикал Индастриз Лимитед Композиции с пролонгированным высвобождением в виде суспензии
US20180104197A9 (en) 2014-05-01 2018-04-19 Sun Pharmaceutical Industries Limited Extended release liquid compositions of metformin
US10258583B2 (en) * 2014-05-01 2019-04-16 Sun Pharmaceutical Industries Limited Extended release liquid compositions of guanfacine
CA2956902A1 (en) 2014-07-30 2016-02-04 Sun Pharmaceutical Industries Limited Dual-chamber pack
US10238803B2 (en) 2016-05-02 2019-03-26 Sun Pharmaceutical Industries Limited Drug delivery device for pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets
WO1985004099A1 (en) * 1984-03-21 1985-09-26 Key Pharmaceuticals, Inc. Sustained release oral dosage form for naproxyn
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
IT1231410B (it) * 1987-09-22 1991-12-04 Cooperativa Farmaceutica Composizione farmaceutica antiinfiammatoria ad effetto prolungato per uso topico
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
IT1226940B (it) * 1988-09-16 1991-02-22 Recordati Chem Pharm Sistema terapeutico a rilascio controllato per formulazioni farmaceutiche liquide
IE902829A1 (en) * 1989-08-14 1991-02-27 Eurand America Microencapsulated taste-masked water-insoluble nsaid drug¹materials
IE66933B1 (en) * 1990-01-15 1996-02-07 Elan Corp Plc Controlled absorption naproxen formulation for once-daily administration

Also Published As

Publication number Publication date
EP0601508A2 (en) 1994-06-15
SG54207A1 (en) 1998-11-16
ES2132163T3 (es) 1999-08-16
ATE178209T1 (de) 1999-04-15
IT1256651B (it) 1995-12-12
ITMI922826A0 (it) 1992-12-11
DE69324214T2 (de) 1999-08-19
EP0601508B1 (en) 1999-03-31
JPH06279274A (ja) 1994-10-04
EP0601508A3 (en) 1995-10-25
DE69324214D1 (de) 1999-05-06

Similar Documents

Publication Publication Date Title
ITMI922826A1 (it) Composizione farmaceutica a rilascio controllato in sospensione liquida
AU6764390A (en) Pharmaceutical granules and drug dosage units made therefrom
MY125662A (en) Pharmaceutical formulations containing darifenacin
BG100933A (en) Polymer coated tablets comprising amoxycilin and clavulanate
CA2058946A1 (en) Formulations for the oral administration of drugs with masked taste
WO1994027557A3 (en) Pharmaceutical thermal infusion process
DE68907762D1 (de) Arzneizubereitung mit gesteuerter wirkstofffreisetzung und verfahren zu deren herstellung.
CA2039197A1 (en) Pharmaceutic Formulation for the Treatment of Alcoholism
DE69638364D1 (de) Formulierungen mit kontrollierter abgabe (albuterol)
PT98397A (pt) Processo para a preparacao de microcapsulas para administracao de uma composicao farmaceutica com libertacao controlada duma proteina ou dum polipeptido mediante integracao com um polimero hidrofobico biodegradavel
DE69816951D1 (de) Zubereitung enthaltend Cefaclor oder Cephalexin mit modifizierter Freisetzungsmatrix
NO930743D0 (no) Systemer for pulserende en-gang-om-dagen-avgivelse for minocyklin
AU6060896A (en) Oral 1alpha-hydroxyprevitamin D
AU4882597A (en) Pharmaceutical preparations for the controlled release of beta-lactam antibiotics
BR9711642A (pt) Uso de uma combinação de amoxicilina e clavulanato na fabricação de medicamento para o tratamento de streptococcus pneumonia resistente a drogas
AU7949294A (en) Pernasal composition and pernasal preparation containing thesame
IL82823A (en) Controlled release oral dosage formulation of a combination of carbidopa and levodopa in the treatment of parkinsonism
ES2160821T3 (es) Uso de una composicion que comprende amoxicilina y acido clavulanico para la produccion de un medicamento para el tratamiento de infecciones bacterianas en pacientes pediatricos.
AU625402B2 (en) Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances
ATE110564T1 (de) Pharmazeutische zusammensetzungen mit verzögerter freisetzung zur oralen verabreichung sowie deren herstellungsverfahren.
ATE212840T1 (de) Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung
MY114610A (en) Controlled drug delivery system for diltiazem.
MX9605055A (es) Tableta revestida de polimero que comprende amoxicilina y clavulanato.
RU93032521A (ru) Способ получения твердого лекарственного препарата для перорального введения

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961230